|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 08836333.8 (espacenet) (Federated) (European Patent Register), 20081003 | Patent/reg. no. and date | DK/EP 2205257, 20130911 | Publication date | 20100714 | Priority no. and date | EP 07291214, 20071005 | EP pub. no. and date |
EP 2205257 20100714 | Effective date | | Applicant/owner | Immutep, Parc Club Orsay 2, Rue Jean Rostand 91400 Orsay, FR | Applicant ref. no. | NGC/GP/147923 | Inventor | TRIEBEL, Frédéric, 10 rue Saint-Louis
F-78000 Versailles, FR | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 38/17 (2006.01) , A61P 35/00 (2006.01) | Title | Doseringsforskrifter for LAG-3Ig (IMP321) til anvendelse ved behandling af cancer | Int. application no. | IB2008002653 | Int. publication no. | WO2009044273 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |